10x Genomics, Inc. (BMV:TXG)

10x Genomics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	49,093	36,223	111,832	81,361	341,127	303,194
Market Cap Growth	38.54%	-67.61%	37.45%	-76.15%	12.51%	119.22%
Enterprise Value	42,142	29,715	107,463	74,414	330,462	289,123
Last Close Price	363.00	440.00	822.81	731.39	3505.33	-
PS Ratio	4.17	2.85	10.69	8.08	33.92	50.99
PB Ratio	3.41	2.45	8.93	5.18	20.35	20.62
P/TBV Ratio	3.74	2.52	9.19	5.36	21.13	21.26
P/OCF Ratio	30.23	260.86	-	-	-	-
EV/Sales Ratio	3.73	2.34	10.27	7.39	32.86	48.62
Debt / Equity Ratio	0.11	0.12	0.13	0.12	0.10	0.09
Asset Turnover	0.65	0.65	0.62	0.50	0.50	0.39
Inventory Turnover	2.56	2.50	2.70	1.70	1.65	2.59
Quick Ratio	3.93	4.09	3.96	4.08	6.10	6.05
Current Ratio	4.48	4.97	4.69	4.85	6.77	6.56
Return on Equity (ROE)	-10.12%	-25.17%	-32.98%	-20.45%	-7.48%	-93.64%
Return on Assets (ROA)	-8.42%	-12.77%	-12.52%	-9.99%	-3.40%	-6.95%
Return on Invested Capital (ROIC)	-9.84%	-14.77%	-14.37%	-11.37%	-3.89%	-8.52%
Return on Capital Employed (ROCE)	-15.00%	-24.00%	-23.80%	-18.20%	-5.80%	-10.50%
Earnings Yield	-2.85%	-10.51%	-3.86%	-3.98%	-0.35%	-3.56%
FCF Yield	3.05%	-0.33%	-0.96%	-3.96%	-0.74%	-1.67%
Buyback Yield / Dilution	-3.07%	-2.80%	-2.90%	-3.18%	-9.09%	-158.76%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.